Knockdown of peroxisome proliferator-activated receptor-Β induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells

Oncogene

Volumn 29, Issue 4, 2010, Pages 516-526

  Yang, L ^a,b   Olsson, B ^a   Pfeifer, D ^a   Jonsson J I ^a   Zhou, Z G ^b   Jiang, X ^b   Fredriksson, B A ^a   Zhang, H ^c   Sun, X F ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF SKÖVDE   (Sweden)

Author keywords

Colon neoplasm; Differentiation; Pathogenesis; Peroxisome proliferator activated receptor; RNA interference

Indexed keywords

ADIPOPHILIN; ANGIOPOIETIN; ANGIOPOIETIN 4; BETA1 INTEGRIN; CARCINOEMBRYONIC ANTIGEN; FATTY ACID BINDING PROTEIN; FIBRONECTIN; INTEGRIN LINKED KINASE; LENTIVIRUS VECTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; COLON CANCER; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; RECTUM CANCER; RNA INTERFERENCE; TUMOR DIFFERENTIATION; WESTERN BLOTTING; ANIMAL; CANCER INVASION; CELL SHAPE; COLON TUMOR; DRUG SCREENING; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; PATHOLOGY; PROTEIN BINDING; RECTUM TUMOR;

AGED; ANIMALS; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION; CELL DIFFERENTIATION; CELL SHAPE; COLONIC NEOPLASMS; FEMALE; FIBRONECTINS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PPAR-BETA; PROTEIN BINDING; RECTAL NEOPLASMS; RNA INTERFERENCE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 75749150060     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.370     Document Type: Article

References (44)

1. Aung CS, Faddy HM, Lister EJ, Monteith GR, Thomas-Roberts SJ. (2006). Isoform specific changes in PPARa and b in colon and breast cancer with differentiation. Biochem Biophys Res Commun 340: 656-660.
2. Alexandrova AY. (2008). Evolution of cell interactions with extracellular matrix during carcinogenesis. Biochemistry 73: 733-741.
3. Barak Y, Liao D, He W, Ong ES, Nelson MC, Olefsky JM. (2002). Effects of peroxisome proliferator-activated receptorb on placenta-tion, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 99: 303-308.
4. Barish GD, Narkar VA, Evans RM. (2006). PPARb: a dagger in the heart of the metabolic syndrome. J Clin Invest 116: 590-597.
5. Burdick AD, Kim DJ, Peraza MA, Gonzalez FJ, Peters JM. (2006). The role of peroxisome proliferator-activated receptor-d in epithelial cell growth and differentiation. Cell Signal 18: 9-20.
6. Bordonaro M, Lazarova DL, Augenlicht LH, Sartorelli AC. (2002). Cell type-and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate. Int J Cancer 97: 42-51.
7. Camps J, Morales C, Prat E, Ribas M, Capella G, Egozcue J et al. (2004). Genetic evolution in colon cancer KM12 cells and metastatic derivates. Int J Cancer 110: 869-874.
8. Cordes N, van Beuningen D. (2003). Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro. Br J Cancer 88: 1470-1479.
9. Chen LC, Hao CY, Chiu YS, Wong P, Melnick JS, Brotman M et al. (2004). Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res 64: 3694-3700.
10. Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N et al. (2004). Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10: 1245-1250.
11. Di-Poi N, Tan NS, Michalik L, Wahli W, Desvergne B. (2002). Antiapoptotic role of PPARb in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 10: 721-733.
12. Doherty UO, Swiggard WJ, Malim MH. (2000). Human immunodeficiency virus type 1 spinoculation enhances infection through Virus Binding. J Virol 74: 10074-10080.
13. Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E et al. (2006). Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 103: 18721-18726.
14. Gupta RA, Tan J, Krause WF, Geraci MW, Willson TM, Dey SK et al. (2000). Prostacyclin-mediated activation of peroxisome proliferator-activated receptor b in colorectal cancer. Proc Natl Acad Sci USA 97: 13275-13280.
15. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L et al. (1996). Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379: 91-96.
16. Hannigan G, Troussard AA, Dedhar S. (2005). Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 5: 51-63.
17. Harman FS, Nicol CJ, Marin HE, Ward JM, Gonzalez FJ, Peters JM. (2004). Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. Nat Med 10: 481-483.
18. He TC, Timotly AC, Bert V, He TC, Chan TA, Vogelstein B et al. (1999). PPARdelta is an APC regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345.
19. Hinnebusch BF, Meng SF, Wu JT, Archer SY, Hodin RA. (2002). The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation1. J Nutr 132: 1012-1017.
20. Holly EH, Michael GB, Andrew NB, Timothy MW, Frank JG, Jeffrey MP. (2008). Ligand activation of peroxisome proli-ferator-activated receptor-b/d (PPARb/d) and inhibition of cyclo-oxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis 29: 169-176.
21. Jeffrey MP, Holly EH, Frank JG. (2008). Role of peroxisome-proliferator- activated receptor b/d (PPARb/d) in gastrointestinal tract function and disease. Clin Sci 115: 107-127.
22. Kim DJ, Akiyama TE, Harman FS, Kim DJ, Akiyama TE, Harman FS et al. (2004). Peroxisome proliferator-activated receptor b-dependent regulation of ubiquatin C expression contributes to attenuation of skin carcinogenesis. J Biol Chem 279: 23719-23727.
23. Kim DJ, Bility MT, Billin AN, Willson TM, Gonzalez FJ, Peters JM. (2006). PPARb selectively induces differentiation and inhibits cell proliferation. Cell Death Differ 13: 53-60.
24. Kliewer SA, Forman BM, Blumberg B, Kliewer SA, Forman BM, Blumberg B et al. (1994). Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359.
25. Lawrie LC, Dundas SR, Curran S, Murray GI. (2004). Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer 90: 1955-1960.
26. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. (1988). Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48: 6863-6871.
27. Orner GA, Dashwood WM, Blum CA, Diaz GD, Li Q, Dashwood RH. (2003). Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 24: 263-267.
28. Ouyang NT, Williams JL, Rigas B. (2006). NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR) delta expression in APCmin/t mice proportionally to their tumor inhibitory effect: Implications for the role of PPARd in carcinogenesis. Carcinogenesis 27: 232-239.
29. Park EY, Dillard A, Williams EA, Wilder ET, Pepper MR, Lane MA. (2005). Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism. Cancer Res 65: 9923-9933.
30. Peraza MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM. (2006). The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci 90: 269-295.
31. Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Tanabe T. (2007). Activation of PPARb/b induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 27: 63-69.
32. Reddig PJ, Juliano RL. (2005). Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev 24: 425-439.
33. Reed KR, Sansom OJ, Hayes AJ, Gescher AJ, Winton DJ, Peters JM et al. (2004). PPARy status and Apc-mediated tumourigenesis in the mouse intestine. Oncogene 23: 8992-8996.
34. Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, Chang S et al. (2004). Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 122: 971-983.
35. Schroeder F, Atshaves BP, Starodub O, Boedeker AL, Smith III RR, Roths JB et al. (2001). Expression of liver fatty acid binding protein alters growth and differentiation of embryonic stem cells. Mol Cell Biochem 219: 127-138.
36. Shao JY, Sheng HM, DuBois RN. (2002). Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res 62: 3282-3288.
37. Takahashi S, Tanaka T, Kodama T, Sakai J. (2006). Peroxisome proliferator-activated receptor b (PPARb), a novel target site for drug discovery in metabolic syndrome. Pharmacol Res 53: 501-507.
38. Targett-Adams P, McElwee MJ, Ehrenborg E, Gustafsson M, Palmer CN, McLauchlan J. (2005). A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. Biochim Biophys Acta 1728: 95-104.
39. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A et al. (2002). The b-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
40. Worth DC, Parsons M. (2008). Adhesion dynamics: Mechanisms and measurements. Int J Biochem Cell Biol 40: 2397-2409.
41. Wozniak MA, Modzelewska K, Kwong L, Keely PJ. (2004). Focal adhesion regulation of cell behavior. Biochim Biophys Acta 1692: 103-119.
42. Yang L, Zhou ZG, Luo HZ, Zhou B, Xia QJ, Tian C. (2006). Quantitative analysis of PPAR-b mRNA by real-time RT-PCR in 86 rectal cancer tissues. Eur J Surg Oncol 32: 181-185.
43. Yang L, Zhou ZG, Zheng XL, Wang L, Yu YY, Zhou B et al. (2008). RNA interference against peroxisome proliferator-activated receptor b gene promotes proliferation of human colorectal cancer cells. Dis Colon Rectum 51: 318-326.
44. Yeatman TJ, Cher ML, Mao WG, Wloch M, Tedesco T. (1996). Identification of genetic alterations associated with the process of human experimental colon cancer liver metastasis in the nude mice. Clin Exp Metastasis 4: 246-252.